JPS6223822B2 - - Google Patents

Info

Publication number
JPS6223822B2
JPS6223822B2 JP55068040A JP6804080A JPS6223822B2 JP S6223822 B2 JPS6223822 B2 JP S6223822B2 JP 55068040 A JP55068040 A JP 55068040A JP 6804080 A JP6804080 A JP 6804080A JP S6223822 B2 JPS6223822 B2 JP S6223822B2
Authority
JP
Japan
Prior art keywords
asn
peptide
lys
arg
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55068040A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56163456A (en
Inventor
Noboru Yanaihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP6804080A priority Critical patent/JPS56163456A/ja
Priority to SE8103198A priority patent/SE454301B/sv
Priority to DK222081A priority patent/DK159163C/da
Priority to FR8110140A priority patent/FR2482861A1/fr
Priority to DE3120312A priority patent/DE3120312C2/de
Priority to GB8115648A priority patent/GB2079289B/en
Priority to BE0/204863A priority patent/BE888906A/fr
Priority to US06/265,926 priority patent/US4407965A/en
Publication of JPS56163456A publication Critical patent/JPS56163456A/ja
Publication of JPS6223822B2 publication Critical patent/JPS6223822B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP6804080A 1980-05-21 1980-05-21 Preparation of antigen Granted JPS56163456A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen
SE8103198A SE454301B (sv) 1980-05-21 1981-05-20 Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp
DK222081A DK159163C (da) 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et tarm-glucagon-antistof
FR8110140A FR2482861A1 (fr) 1980-05-21 1981-05-21 Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
DE3120312A DE3120312C2 (de) 1980-05-21 1981-05-21 Verfahren zur Herstellung von Darm-Glucagon-Antigenen und deren Verwendung
GB8115648A GB2079289B (en) 1980-05-21 1981-05-21 Process for preparing antibody
BE0/204863A BE888906A (fr) 1980-05-21 1981-05-21 Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
US06/265,926 US4407965A (en) 1980-05-21 1981-05-21 Process for preparing antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Publications (2)

Publication Number Publication Date
JPS56163456A JPS56163456A (en) 1981-12-16
JPS6223822B2 true JPS6223822B2 (enExample) 1987-05-25

Family

ID=13362282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6804080A Granted JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Country Status (8)

Country Link
US (1) US4407965A (enExample)
JP (1) JPS56163456A (enExample)
BE (1) BE888906A (enExample)
DE (1) DE3120312C2 (enExample)
DK (1) DK159163C (enExample)
FR (1) FR2482861A1 (enExample)
GB (1) GB2079289B (enExample)
SE (1) SE454301B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249395A (en) * 1982-09-30 1989-01-24 Tetsuya Tachikawa Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
WO1986001834A1 (en) * 1984-09-19 1986-03-27 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JPH0792458B2 (ja) * 1986-03-14 1995-10-09 郁男 山科 糖鎖特異抗体アツセイプレ−ト及びその製造方法
US5202270A (en) * 1986-05-15 1993-04-13 Abbott Laboratories Cocaine and cocaine metabolites assay tracers, immunogens and antibodies
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
BR112017005110A2 (pt) 2014-09-16 2018-01-23 Regeneron Pharma anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo, molécula isolada de ácido nucleico, composição farmacêutica, e, método para diminuir níveis de glicose no sangue ou para tratar uma condição ou doença.
JP7173962B2 (ja) 2016-08-30 2022-11-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド グルカゴン受容体シグナル伝達の干渉による重度のインスリン抵抗性の処置方法
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Also Published As

Publication number Publication date
DK159163C (da) 1991-02-11
DE3120312A1 (de) 1982-03-04
DK159163B (da) 1990-09-10
GB2079289B (en) 1983-10-26
DK222081A (da) 1981-11-22
US4407965A (en) 1983-10-04
FR2482861A1 (fr) 1981-11-27
SE454301B (sv) 1988-04-18
DE3120312C2 (de) 1985-08-29
GB2079289A (en) 1982-01-20
JPS56163456A (en) 1981-12-16
FR2482861B1 (enExample) 1983-09-09
BE888906A (fr) 1981-11-23
SE8103198L (sv) 1981-11-22

Similar Documents

Publication Publication Date Title
Muller et al. Cholecystokinin and its COOH-terminal octapeptide in the pig brain.
Bernatowicz et al. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent
Li et al. Human pituitary growth hormone: XIX. The primary structure of the hormone
US4407965A (en) Process for preparing antibody
JPH02221296A (ja) ホロレナ・クルタくも毒液から単離されたポリペプチド類
GB2062644A (en) Glucagon fragment and utility hereof
JPS63146897A (ja) 癌遺伝子関連ペプチド
CA2161480A1 (en) Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody
Rasmussen et al. Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas
Büllesbach et al. Chemical synthesis of a Zwitterhormon, insulaxin, and of a relaxin-like bombyxin derivative
JPS61112099A (ja) 新規ポリペプチド及びその製造法
JPH0160480B2 (enExample)
EP0446797B1 (de) Synthetische Peptide, die Sequenzen aus Faktor VIIa enthalten und deren Verwendung
JPH0453880B2 (enExample)
JPH0160780B2 (enExample)
JPH0160779B2 (enExample)
JPH0160040B2 (enExample)
JPS6120560B2 (enExample)
JPH0160036B2 (enExample)
JPH0160038B2 (enExample)
JPH0224280B2 (enExample)
JPH0160037B2 (enExample)
JPH0339518B2 (enExample)
JP2603487B2 (ja) ガンに罹患している疑いのあるヒトをスクリーニングする方法
JP2001226371A (ja) ダイオキシン誘導体およびこれを使用した測定法